Nov 21 (Reuters) - Cerus Corp. on Tuesday said it received European regulatory approval to market its blood safety enhancement product for plasma throughout the European Union. The biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results